New Antifungal Drugs, New Approaches and Vaccines Antifungal name Choose antifungalAlbaconazoleAlpha-asaroneAmorolfineAR-12ASP2397 (VL-2397)ASP9726AuranofinAureobasidin ABHBMBiafungin (CD101)CD101Ceragenin CSA-131CorifunginE1210Encochleated AmB (MAT023)EV-086F901318 (olorofim)FG 3622FK506 (tacrolimus) and L-685,818FR290581General articlesGM 237354GriseofulvinHaemofunginIbomycinIbrexafungerp (SCY-078, MK-3118)Icofungipen (PLD-118)Ilicicolin HKOSN-2079 (polyketide)L365L743L884Macrocyclic amidinoureasManumycin AMAT2203MGCD290MycograbMyriocinNebulised AmpBNikkomycin ZNovamycin (NP339)Novexatin (NP213)P11-6PC945PolyoxinPradimicins (inc. BMS-181184)R-135853SampangineSM21SPK-843StatinsT-2307TacrolimusTavaborole (AN2690)TipifarnibTurbinmicinVaccinesVT-1129VT-1161VT-1598YO-001A Showing 10 posts of 219 posts found. Title Trail phase Date Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates 31 March 2015 Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species 3 January 2015 F2G Ltd Announces the Acceptance of F901318 to Participate in the EMA’s Adaptive Pathways Pilot Programme. 3 December 2015 Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic Varnish (COOL) Phase 4 8 December 2014 A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis 8 August 2013 Polyoxin and nikkomycin analogs: Recent design and synthesis of novel peptidyl nucleosides 1 December 2013 Valley Fever Drug Treatment Receives Fast-Track Designation by the FDA Under GAIN Act 4 October 2014 Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology. 1 February 2012 Cidara Therapeutics to Present Data from Antifungal Drug Development Programs at ICAAC/ICC 2015 Meeting Phase 1 10 August 2015 Cidara Therapeutics QIDP and Fast Track designations, USA (candidemia and candidiasis). Phase 1 11 May 2015 Previous1...910111213141516171819202122Next